(Q30423093)

21 June 2017

1 reference

23 October 2022

Immunopathogenesis of 2009 pandemic influenza (English)

1 reference

21 June 2017

0 references

1 reference

Jesus F Bermejo-Martin

0 references

author name string

Raquel Almansa

series ordinal

1

1 reference

21 June 2017

Jesús F Bermejo-Martín

series ordinal

2

1 reference

21 June 2017

Raúl Ortiz de Lejarazu Leonardo

series ordinal

3

1 reference

21 June 2017

publication date

1 October 2012

2 references

Infectious Diseases and Clinical Microbiology

21 June 2017

23 October 2022

2 references

21 June 2017

23 October 2022

30 Suppl 4

1 reference

21 June 2017

page(s)

18-24

1 reference

Europe's initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Influenza A(H1N1)v in Germany: the first 10,000 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Critical care services and 2009 H1N1 influenza in Australia and New Zealand.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Critically ill patients with 2009 influenza A(H1N1) infection in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009.

2 references

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

12 December 2020

Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Factors associated to admission to Intensive Care in patients hospitalized due to pandemic Influenza A/H1N1 2009

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Respiratory epithelial cells in innate immunity to influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Persistence of proinflammatory response after severe respiratory syncytial virus disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

The 2009 pandemic H1N1 and triple-reassortant swine H1N1 influenza viruses replicate efficiently but elicit an attenuated inflammatory response in polarized human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Clinical aspects and cytokine response in severe H1N1 influenza A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Host innate defenses in the lung: the role of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Virus-specific CD8+ T cells in primary and secondary influenza pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Interleukin-17 and systemic lupus erythematosus: current concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Th17 cells: effector T cells with inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Development and function of TH17 cells in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Inflammatory profiles in severe pneumonia associated with the pandemic influenza A/H1N1 virus isolated in Mexico City.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Host adaptive immunity deficiency in severe pandemic influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Analysis of serum cytokines in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

An interferon-gamma-related cytokine storm in SARS patients

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Respiratory syncytial virus causes increased bronchial epithelial permeability

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Innate immune evasion strategies of influenza viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Severe respiratory disease concurrent with the circulation of H1N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Cross-reacting antibodies against the pandemic (H1N1) 2009 influenza virus in older Australians.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Antigen-Antibody docking reveals the molecular basis for cross-reactivity of the 1918 and 2009 Influenza A/H1N1 pandemic viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Complete-proteome mapping of human influenza A adaptive mutations: implications for human transmissibility of zoonotic strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Assessment of seasonal influenza A virus-specific CD4 T-cell responses to 2009 pandemic H1N1 swine-origin influenza A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Lack of CD200 enhances pathological T cell responses during influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Role of alveolar epithelial early growth response-1 (Egr-1) in CD8+ T cell-mediated lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Lung pathology in fatal novel human influenza A (H1N1) infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Effect of the novel influenza A (H1N1) virus in the human immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

H1N1 2009 influenza virus infection during pregnancy in the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

2009 pandemic influenza A (H1N1) and vaccine failure in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1).

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Obese mice have increased morbidity and mortality compared to non-obese mice during infection with the 2009 pandemic H1N1 influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Emerging infectious disease outbreaks: old lessons and new challenges for obstetrician-gynecologists.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Peripheral blood cytokine profiling during pregnancy and post-partum periods

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Wild type and mutant 2009 pandemic influenza A (H1N1) viruses cause more severe disease and higher mortality in pregnant BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Fatal outcome of pandemic H1N1 2009 influenza virus infection is associated with immunopathology and impaired lung repair, not enhanced viral burden, in pregnant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Overcoming steroid unresponsiveness in airways disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Molecular mechanisms of corticosteroid resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Macrolides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Systemic release of high mobility group box 1 protein during severe murine influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Confronting an influenza pandemic with inexpensive generic agents: can it be done?

1 reference

https://api.crossref.org/works/10.1016%2FS0213-005X%2812%2970100-3

7 January 2021

Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses

1 reference

12 December 2020

Macrolide therapy in respiratory viral infections

1 reference

12 December 2020

The effector T helper cell triade.

1 reference

12 December 2020

Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection.

1 reference

12 December 2020

New influenza A (H1N1) 2009 in Singapore: the first ten adult imported cases.

1 reference

12 December 2020

The immune response to influenza infection

1 reference

12 December 2020

Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD

1 reference

12 December 2020

Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients

1 reference

12 December 2020

Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection

1 reference

12 December 2020

Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April-June 2009.

1 reference

12 December 2020

10.1016/S0213-005X(12)70100-3

Identifiers

DOI

1 reference

release_to2urp34zfecfiqtn2giuerjvq

21 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/to2urp34zfecfiqtn2giuerjvq

24 November 2022

mapped directly with Wikidata item

PMC publication ID

7130369

0 references

1 reference